Restoril and Peripancreatic fluid collection - a phase IV clinical study of FDA data


Peripancreatic fluid collection is reported only by a few people who take Restoril.

The phase IV clinical study analyzes which people take Restoril and have Peripancreatic fluid collection. It is created by eHealthMe based on reports of 12,251 people who have side effects while taking Restoril from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 13, 2022

12,251 people reported to have side effects when taking Restoril.
Among them, 4 people (0.03%) have Peripancreatic fluid collection.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 12,879 Restoril users for its effectiveness, alternative drugs and more.

What is Peripancreatic fluid collection?

Peripancreatic fluid collection is found to be associated with 168 drugs and 86 conditions by eHealthMe.

Number of Restoril and Peripancreatic fluid collection reports submitted per year:

Could Restoril cause Peripancreatic fluid collection?

Gender of people who have Peripancreatic fluid collection when taking Restoril *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Peripancreatic fluid collection when taking Restoril *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Restoril *:

  1. Zofran: 4 people, 100.00%
  2. Percocet: 4 people, 100.00%
  3. Compazine: 4 people, 100.00%
  4. Droperidol: 4 people, 100.00%
  5. Heparin: 4 people, 100.00%
  6. Lasix: 4 people, 100.00%
  7. Lipitor: 4 people, 100.00%
  8. Mycelex: 4 people, 100.00%
  9. Nystatin: 4 people, 100.00%
  10. Vancomycin: 4 people, 100.00%

Common side effects people have besides Peripancreatic fluid collection *:

  1. Gallstones (stone formation by bile component): 4 people, 100.00%
  2. Foot Ulcer: 4 people, 100.00%
  3. Incisional Drainage: 3 people, 75.00%
  4. Abdominal Adhesions (inflammation of abdomen): 3 people, 75.00%
  5. Hypotension (abnormally low blood pressure): 2 people, 50.00%
  6. Diabetes Mellitus Aggravated (serious diabetes): 2 people, 50.00%
  7. Blood Glucose Increased: 2 people, 50.00%
  8. White Blood Cell Count Decreased: 1 person, 25.00%
  9. Septicaemia Pseudomonal (blood infection by bacteria): 1 person, 25.00%
  10. Incision Site Haemorrhage (bleeding from incision site): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Restoril and have Peripancreatic fluid collection?

Check whether Peripancreatic fluid collection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Peripancreatic fluid collection and when was it recovered:

Expand to all the drugs that have ingredients of temazepam:

Alternative drugs to, pros and cons of Restoril:

Common Restoril side effects:

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Peripancreatic fluid collection treatments and more:

COVID vaccines that are related to Peripancreatic fluid collection:

All the drugs that are associated with Peripancreatic fluid collection:

All the conditions that are associated with Peripancreatic fluid collection:

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Restoril) and Restoril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: